Alzheimer disease biomarkers may aid in the prognosis of MCI cases initially reverted to normal.
Lisa VermuntAlegría J L van PaasenCharlotte E TeunissenPhilip ScheltensPieter Jelle VisserBetty M Tijmsnull nullPublished in: Neurology (2019)
In MCI reverters, abnormal biomarkers for AD pathology are associated with subsequent decline. AD biomarkers may aid in the prognosis of reverting MCI.
Keyphrases